Randox Teo expands its R&D facility in An Clochán Liath with a €0.5m investment

3 May, 2013

min read

Randox Teo today announced that it is to invest a further €0.5m as it expands its R&D facility in An Clochán Liath, Co. Donegal, with the support of Údarás na Gaeltachta through the national Research & Development & Innovation scheme. Randox Teo’s strategy is driven by the need to provide the market with high quality, fast and informative diagnostic data to enable early identification of diseases which will in turn assist practitioners in caring for patients in the short to long term.

This particular investment will focus on the development of new technologies for multiplex testing for kidney disease, Alzheimer’s disease and lung cancers.

Speaking to the Board of Údarás na Gaeltachta today who were visiting the facility, Dr. Peter Fitzgerald, owner and MD of Randox Holdings Ltd said, “This investment is another step towards establishing a world class diagnostic research and development centre in An Clochán Liath. We aim to develop new and improved technology used to aid in the diagnosis of cancer and other human diseases, and bring these products to market from this facility.”

The company currently employs 42 people in an Clochán Liath and expects to increase its employment to 130 by the end of 2015.

Anna Ní Ghallachair, Chairperson of Údarás na Gaeltachta stated “This investment helps to copper-fasten the future development of this enterprise in An Clochán Liath. It’s encouraging to see the high quality of employment that is provided to local people by this company and this new investments is a move towards the creation further good quality jobs in manufacturing, engineering, research and development, and marketing.”

The Minister of State at the Department of Arts, Heritage and the Gaeltacht, Dinny McGinley, T.D., who was also present, welcomed the investment and commended Údarás na Gaeltachta on its continuous work with Randox and this development in An Clochán Liath.

More information:
Randox Laboratories manufactures a range of clinical chemistry and biochip analysers for the health and research sectors globally. Its products are used in over 145 countries worldwide by hospitals, research and forensic laboratories, pharmaceutical companies, sports testing authorities and veterinary clinics. The Randox facility in An Clochán Liath currently supplies the company’s clinical analyser product and houses one of the company’s main R&D laboratories.

In 2008 Randox Laboratories Ltd announced that it was to establish a diagnostic manufacturing and R&D facility in An Clochán Liath with a total investment of €7.5 million with assistance from Údarás na Gaeltachta. In 2011 the company demonstrated its commitment to the area by purchasing the building it leased from Údarás na Gaeltachta at the time.

Evidence shows that clinical diagnostics are taking centre-stage in the fight for improved health. It is commonly acknowledged that as much as 70% of the information used by medical personnel to make a diagnosis is information sourced from the laboratory. Randox is helping through research and development with improved diagnostic systems to present more patient information to the medical professionals.